Syed M. Abbas Rizvi
Centre for Experimental Radiation Oncology (CERO)
Division of Cancer Services
St George Hospital
Kogarah
Australia
Name/email consistency: high
- Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205/Bismuth-206. Abbas Rizvi, S.M., Song, E.Y., Raja, C., Beretov, J., Morgenstern, A., Apostolidis, C., Russell, P.J., Kearsley, J.H., Abbas, K., Allen, B.J. Cancer Biol. Ther. (2008)
- Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model. Abbas Rizvi, S.M., Li, Y., Song, E.Y., Qu, C.F., Raja, C., Morgenstern, A., Apostolidis, C., Allen, B.J. Cancer Biol. Ther. (2006)